Notify me when JOHN G ULLMAN & ASSOCIATES INC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 179 | $749,965,685 | +$28,840,311 | -$60,475,186 | -$31,634,875 | TSM, EMR, GLW, CSCO, TEL | 13F-HR | 05 Feb 2026, 15:51 |
| Q3 2025 | 173 | $742,668,709 | +$44,548,079 | -$66,934,270 | -$22,386,191 | TSM, EMR, GLW, AVGO, OGE | 13F-HR | 05 Nov 2025, 11:10 |
| Q2 2025 | 174 | $673,817,343 | +$7,752,884 | -$42,797,473 | -$35,044,589 | EMR, TSM, GLW, IBM, AVGO | 13F-HR | 29 Jul 2025, 15:16 |
| Q1 2025 | 170 | $648,356,422 | +$29,866,451 | -$33,720,123 | -$3,853,672 | EMR, GLW, OGE, TSM, CSCO | 13F-HR | 06 May 2025, 15:06 |
| Q4 2024 | 172 | $679,638,492 | +$42,475,179 | -$64,847,994 | -$22,372,815 | EMR, GLW, TSM, IBM, OGE | 13F-HR | 05 Feb 2025, 14:57 |
| Q3 2024 | 179 | $695,519,084 | +$75,443,689 | -$67,539,640 | +$7,904,049 | EMR, GLW, IBM, TSM, OGE | 13F-HR | 08 Nov 2024, 16:00 |
| Q2 2024 | 179 | $655,474,222 | +$41,386,059 | -$33,157,494 | +$8,228,565 | EMR, GLW, TSM, IBM, OGE | 13F-HR | 08 Aug 2024, 14:46 |
| Q1 2024 | 174 | $651,817,532 | +$25,949,363 | -$47,473,714 | -$21,524,351 | EMR, GLW, IBM, TSM, OGE | 13F-HR | 06 May 2024, 12:01 |
| Q4 2023 | 169 | $630,462,615 | +$45,792,957 | -$66,530,711 | -$20,737,754 | EMR, GLW, IBM, OGE, BMY | 13F-HR | 31 Jan 2024, 13:44 |
| Q3 2023 | 173 | $611,335,821 | +$16,661,761 | -$27,541,331 | -$10,879,570 | EMR, GLW, BMY, CSCO, PFE | 13F-HR | 01 Nov 2023, 15:28 |
| Q2 2023 | 177 | $648,139,520 | +$32,481,463 | -$35,702,445 | -$3,220,982 | EMR, GLW, BMY, PFE, OGE | 13F-HR | 21 Aug 2023, 09:27 |
| Q1 2023 | 177 | $642,976,000 | +$40,000,343 | -$26,856,777 | +$13,143,566 | EMR, GLW, BMY, PFE, OGE | 13F-HR | 05 May 2023, 14:01 |
| Q4 2022 | 169 | $627,196,000 | +$25,785,026 | -$48,884,315 | -$23,099,289 | EMR, PFE, BMY, GLW, XOM | 13F-HR | 08 Feb 2023, 12:01 |
| Q3 2022 | 157 | $571,531,000 | +$41,916,921 | -$43,656,957 | -$1,740,036 | EMR, BMY, PFE, GLW, OGE | 13F-HR | 19 Oct 2022, 11:00 |
| Q2 2022 | 157 | $623,153,000 | +$40,094,115 | -$64,981,242 | -$24,887,127 | PFE, EMR, BMY, OGE, GLW | 13F-HR | 27 Jul 2022, 13:43 |
| Q1 2022 | 168 | $721,180,000 | +$33,888,705 | -$26,323,847 | +$7,564,858 | EMR, PFE, OGE, BMY, GLW | 13F-HR | 29 Apr 2022, 10:12 |
| Q4 2021 | 162 | $727,098,000 | +$27,476,087 | -$79,725,299 | -$52,249,212 | PFE, EMR, OGE, CSCO, BMY | 13F-HR | 26 Jan 2022, 13:55 |
| Q3 2021 | 159 | $735,267,000 | +$34,767,306 | -$42,458,000 | -$7,690,694 | EMR, PFE, OGE, VZ, GLW | 13F-HR | 02 Nov 2021, 13:49 |
| Q2 2021 | 156 | $767,586,000 | +$37,795,271 | -$35,791,178 | +$2,004,093 | EMR, OGE, BMY, PFE, GLW | 13F-HR | 23 Jul 2021, 11:18 |
| Q1 2021 | 154 | $745,448,000 | +$73,623,800 | -$37,779,611 | +$35,844,189 | EMR, GLW, BMY, INTC, PFE | 13F-HR | 22 Apr 2021, 15:08 |
| Q4 2020 | 152 | $645,075,000 | +$119,000,958 | -$16,216,293 | +$102,784,665 | EMR, BMY, GLW, PFE, INTC | 13F-HR | 05 Feb 2021, 13:42 |
| Q3 2020 | 128 | $483,155,000 | +$62,626,184 | -$9,853,397 | +$52,772,787 | EMR, BMY, GLW, PFE, INTC | 13F-HR | 06 Nov 2020, 10:31 |
| Q2 2020 | 109 | $409,772,000 | +$32,373,991 | -$50,152,366 | -$17,778,375 | EMR, BMY, PFE, GLW, GSK | 13F-HR | 29 Jul 2020, 13:56 |
| Q1 2020 | 100 | $376,968,000 | +$28,215,627 | -$115,677,562 | -$87,461,935 | EMR, BMY, GLW, PFE, GSK | 13F-HR | 14 Apr 2020, 13:18 |
| Q4 2019 | 142 | $580,915,000 | +$29,261,365 | -$38,996,055 | -$9,734,690 | EMR, BMY, GLW, PFE, XOM | 13F-HR | 29 Jan 2020, 14:34 |
| Q3 2019 | 144 | $550,565,000 | +$43,813,080 | -$48,209,563 | -$4,396,483 | EMR, XOM, GLW, BMY, PFE | 13F-HR | 21 Oct 2019, 14:07 |
| Q2 2019 | 148 | $568,572,000 | +$54,767,436 | -$44,664,156 | +$10,103,280 | EMR, XOM, GVA, GLW, PFE | 13F-HR | 02 Aug 2019, 14:11 |
| Q1 2019 | 128 | $552,324,000 | +$30,412,823 | -$30,567,711 | -$154,888 | EMR, XOM, GVA, GLW, PFE | 13F-HR | 30 Apr 2019, 14:49 |
| Q4 2018 | 129 | $495,766,000 | +$56,580,712 | -$43,012,015 | +$13,568,697 | EMR, XOM, GLW, PFE, GVA | 13F-HR | 29 Jan 2019, 13:01 |
| Q3 2018 | 129 | $550,035,000 | +$33,542,282 | -$42,549,528 | -$9,007,246 | XOM, EMR, GLW, PFE, MRK | 13F-HR | 02 Nov 2018, 14:46 |
| Q2 2018 | 114 | $528,756,000 | +$33,708,022 | -$27,228,171 | +$6,479,851 | XOM, EMR, JNJ, GLW, SLB | 13F-HR | 23 Jul 2018, 13:53 |
| Q1 2018 | 114 | $517,174,000 | +$44,162,837 | -$22,846,233 | +$21,316,604 | XOM, EMR, JNJ, GLW, SLB | 13F-HR | 19 Apr 2018, 14:49 |
| Q4 2017 | 114 | $501,269,000 | +$24,416,533 | -$57,002,353 | -$32,585,820 | EMR, XOM, JNJ, GLW, SLB | 13F-HR | 31 Jan 2018, 09:48 |
| Q3 2017 | 108 | $512,870,000 | +$28,689,967 | -$40,621,163 | -$11,931,196 | XOM, JNJ, EMR, GLW, PFE | 13F-HR | 03 Nov 2017, 09:50 |
| Q2 2017 | 113 | $503,962,000 | +$38,265,233 | -$28,868,101 | +$9,397,132 | JNJ, GLW, XOM, EMR, PFE | 13F-HR | 26 Jul 2017, 15:58 |
| Q1 2017 | 116 | $483,675,000 | +$30,286,546 | -$44,565,250 | -$14,278,704 | JNJ, GLW, XOM, EMR, PFE | 13F-HR | 25 Apr 2017, 14:48 |
| Q4 2016 | 119 | $477,340,000 | +$24,246,386 | -$47,647,791 | -$23,401,405 | JNJ, GLW, EMR, XOM, PFE | 13F-HR | 20 Jan 2017, 16:22 |
| Q3 2016 | 115 | $486,246,000 | +$27,644,986 | -$44,052,081 | -$16,407,095 | JNJ, GLW, EMR, XOM, PFE | 13F-HR | 20 Oct 2016, 14:50 |
| Q2 2016 | 116 | $486,962,000 | +$49,732,035 | -$12,309,625 | +$37,422,410 | JNJ, GLW, XOM, EMR, PFE | 13F-HR | 22 Jul 2016, 08:30 |
| Q1 2016 | 104 | $426,210,000 | +$30,614,908 | -$79,090,567 | -$48,475,659 | JNJ, GLW, XOM, EMR, GVA | 13F-HR | 27 Apr 2016, 12:27 |
| Q4 2015 | 114 | $452,559,000 | +$40,797,317 | -$37,705,557 | +$3,091,760 | JNJ, GLW, KO, XOM, EMR | 13F-HR | 11 Feb 2016, 12:27 |
| Q3 2015 | 121 | $421,470,000 | +$36,982,101 | -$104,956,664 | -$67,974,563 | JNJ, GLW, KO, XOM, PFE | Restatement | 23 Oct 2015, 10:26 |
| Q2 2015 | 144 | $531,241,000 | +$37,304,946 | -$28,756,675 | +$8,548,271 | JNJ, GLW, XOM, EMR, KO | 13F-HR | 11 Aug 2015, 11:03 |
| Q1 2015 | 141 | $526,156,000 | +$32,522,402 | -$29,794,626 | +$2,727,776 | JNJ, GLW, XOM, EMR, KO | 13F-HR | 13 May 2015, 12:56 |
| Q4 2014 | 145 | $531,059,000 | +$32,388,614 | -$45,022,740 | -$12,634,126 | JNJ, GLW, XOM, EMR, KO | 13F-HR | 26 Jan 2015, 14:34 |
| Q3 2014 | 148 | $519,857,000 | +$24,655,719 | -$40,754,287 | -$16,098,568 | JNJ, XOM, GLW, EMR, KO | 13F-HR | 12 Nov 2014, 10:39 |
| Q2 2014 | 152 | $547,546,000 | +$24,645,314 | -$32,576,468 | -$7,931,154 | JNJ, GLW, XOM, EMR, KO | 13F-HR | 18 Jul 2014, 15:23 |
| Q1 2014 | 147 | $539,890,000 | +$30,047,797 | -$30,786,282 | -$738,485 | JNJ, GLW, XOM, EMR, KO | 13F-HR | 07 May 2014, 10:03 |
| Q4 2013 | 149 | $523,846,000 | $0 | $0 | $0 | JNJ, XOM, GLW, EMR, KO | 13F-HR | 03 Feb 2014, 13:09 |